Clinical Trials
6 trialsNCT03970447 2026-05-15
GBM AGILE
Global Coalition for Adaptive Research
Phase 2/3 Recruiting
NCT02986178 2025-07-11
Lerapolturev in Recurrent Malignant Glioma
Istari Oncology, Inc.
Phase 2 Completed
NCT02765165 2021-07-23
Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Proximagen, LLC
Phase 1/2 Terminated
NCT02414165 2020-02-07
Toca5
Tocagen Inc.
Phase 2/3 Terminated
NCT01562197 2019-01-24
AxiGII
Universitair Ziekenhuis Brussel
Phase 2 Completed
NCT01737346 2012-12-03
Procarbazine and Lomustine in Recurrent Glioblastoma
Incheon St.Mary's Hospital
Phase 2 Unknown